Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – In postmenopausal women with node-positive early breast cancer, substituting docetaxel for epirubicin for the last three cycles of chemotherapy may improve outcome without…
NEW YORK (Reuters Health) – An investigational agent, ARC1779, reduces cerebral emboli resulting from carotid endarterectomy by inhibiting the prothrombotic effects of von Willebrand factor (vWF), according to…
NEW YORK (Reuters Health) – When used as adjuvant therapy in high-risk breast cancer or as primary treatment for metastatic breast cancer, high-dose chemotherapy (HDC) with autologous stem-cell…
NEW YORK (Reuters Health) – In select patients with American Joint Committee on Cancer (AJCC) stage II colon cancer, adjuvant chemotherapy after resection improves survival, according to a…
NEW YORK (Reuters Health) – In patients with atrial fibrillation (AF), combination antithrombotic therapy with an anticoagulant and an antiplatelet increases the risk for clinically relevant bleeding with…
NEW YORK (Reuters Health) – Patients with previously untreated multiple myeloma do better when they are given an autologous stem-cell transplant followed by an allogeneic transplant from a…
NEW YORK (Reuters Health) – Among older women with breast cancer, specific comorbid conditions are independently associated with decreased survival, according to a report in the Journal of…
NEW YORK (Reuters Health) – Argon plasma coagulation (APC) in combination with another method of esophageal recanalization is better than APC alone as palliative therapy in patients with…
NEW YORK (Reuters Health) – Venous thromboembolism (VTE) after colorectal surgery is nearly twice as common when a patient undergoes an open procedure compared to laparoscopy, a study…
NEW YORK (Reuters Health) – While angiotensin receptor blockers (ARBs) as a class do not appear to be associated with an increased malignancy risk in patients with diabetes,…
